Cargando…
Conventional heart failure therapy in cardiac ATTR amyloidosis
AIMS: The aims of this study were to assess prescription patterns, dosages, discontinuation rates, and association with prognosis of conventional heart failure medications in patients with transthyretin cardiac amyloidosis (ATTR-CA). METHODS AND RESULTS: A retrospective analysis of all consecutive p...
Autores principales: | Ioannou, Adam, Massa, Paolo, Patel, Rishi K, Razvi, Yousuf, Porcari, Aldostefano, Rauf, Muhammad U, Jiang, Anita, Cabras, Giacomo, Filisetti, Stefano, Bolhuis, Roos E, Bandera, Francesco, Venneri, Lucia, Martinez-Naharro, Ana, Law, Steven, Kotecha, Tushar, Virsinskaite, Ruta, Knight, Daniel S, Emdin, Michele, Petrie, Aviva, Lachmann, Helen, Wechelakar, Ashutosh, Petrie, Mark, Hughes, Alun, Freemantle, Nick, Hawkins, Philip N, Whelan, Carol, McMurray, John J V, Gillmore, Julian D, Fontana, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424879/ https://www.ncbi.nlm.nih.gov/pubmed/37216684 http://dx.doi.org/10.1093/eurheartj/ehad347 |
Ejemplares similares
-
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years
por: Ioannou, Adam, et al.
Publicado: (2022) -
Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
por: Ioannou, Adam, et al.
Publicado: (2023) -
Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023) -
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome:
the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022) -
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation( )
por: Kondo, Toru, et al.
Publicado: (2022)